-
Travelers returning from Africa are at risk for having acquired spotted fever rickettsiosis. The diagnosis can be missed if convalescent sera are obtained too early; therefore, convalescent specimens should be obtained at least 28 days after the onset of illness.
-
Dr. Robert Gilman convened an important symposium on neurocysticercosis at the annual meeting of the American Society of Tropical Medicine and Hygiene. During that symposium, Dr. Theodore Nash from NIAID reported on the increasing evidence indicating that calcific neurocysticercosis is not necessarily clinically inactive, but may be a cause of seizures and focal symptoms associated with episodic perilesional edema.
-
A new preadmission program at the University of California (UC) Davis Health System is building a stronger link between hospital and physicians office and identifying issues much earlier in the process issues that might affect length of stay (LOS).
-
On-line university offers controversial course.
-
Federal laws aimed at encouraging drug companies to study how well their products work in children have had the unintended consequence of weakening already vague protections that prevent child research subjects from being exploited, a leading human subjects research advocate claims.
-
Just about a year ago, the Privacy Rule, which is a part of the Health Insurance Portability and Accountability Act (HIPAA) regulations, became enforceable. Already, complaints are coming in and investigations are being launched some against mighty organizations such as Kaiser Permanente.
-
Knowledge is power, and knowing how an audit works can help you sail through, says Erich K. Jensen. Jensen has developed a course designed specifically to highlight what happens during an FDA audit and what can be done to make the process as easy as possible.
-
-
An experimental blood oxygenation device has the potential to help thousands of patients with severe emphysema or other lung conditions. The device has been thoroughly tested in laboratory animals, but human trials would involve major invasive procedures for research participants and place them at very high risk of death or serious complications.
-
Paramedics in the Denver area will be administering an experimental blood substitute to patients who meet certain criteria under an unusual research protocol that allows patients to be recruited without giving informed consent.
